Solar Systems Provider Array Technologies Shines As The IBD Stock Of The Day – Investor's Business Daily
BREAKING: Market Falls Despite Jobs Report
Composite Rating
Industry Group Ranking
Emerging Pattern
Cup with Handle
A positive chart pattern named such because it resembles the outline of a coffee cup with a handle. The pattern can last from seven weeks to as long as a year, but most are three to six months.
Array Technologies (ARRY) is the IBD Stock Of The Day, as this player in solar power recently reversed a streak of quarterly losses. And ARRY stock is shaping up for a possible entry.
Array designs and manufactures solar tracking systems. These allow ground-mounted solar panels to rotate and follow the sun throughout the day.
ARRY stock is relatively new to the stock market, having launched its initial public offering in October 2020. And ARRY stock has performed well of late, given the downturn over the past year.
On Aug. 9, Array reported second-quarter earnings that beat Wall Street predictions. The company snapped its streak of quarterly losses stretching back to the third quarter of last year.
Earnings skyrocketed 116% to $424.9 million for the quarter, well above analyst views for $362.2 million. And per-share earnings improved over the year to 9 cents from 7 cents, beating the FactSet estimate of 2 cents.
Array saw 79% growth in its legacy operations segment and its gross margins improved for the third-straight quarter, according to the latest report. Following the second-quarter results, Truist Securities raised its price target for ARRY stock to $23 from $13.
But in a note to clients, Truist analyst Bronson Fleig said the company is seeing margin pressure related to its $652 million acquisition of STI Norland back in January.
Flieg says there will be a focus on “margin restoration and materialization of expected growth tailwinds,” following the stock’s recent outperformance.
Array also affirmed its full-year outlook with the report. It projects revenue to range from $1.3 billion to $1.5 billion and earnings between 25 cents and 35 cents a share. Analysts see earnings of 31 cents a share on $1.4 billion in revenue.
ARRY stock offers high ratings, as solar and energy issues have held up better than the broader markets. And the Energy-Solar group is the top-performing sector according to IBD Stock Checkup.
Array ranks sixth in the group while its rivals Daqo New Energy (DQ), Enphase Energy (ENPH), Canadian Solar (CSIQ) and JinkoSolar Holdings (JKS) make up the top four performers.
And ARRY stock currently has a perfect 99 Relative Strength Rating, indicating top-notch performance against its peers in the S&P 500 over the last 12 months. ARRY shares have a muscular 90 Composite Rating. The Composite Rating combines a number of key technical indicators into one easy-to-read score. However, its EPS Rating of 41 has room for improvement.
ARRY stock is forming a handle on a deep cup base. But if the handle draws out long enough it could potentially form its own base. Shares are holding above its 21-day exponential moving average for now. Shares climbed 2.7% Thursday to close at 21.46.
ARRY stock currently has a buy point of 24.10, but a downward-sloping trendline or strong bounce off its 21-day line could provide other possible entries. However, the major indexes fell Thursday on mixed economic reports. Investors should proceed with caution while the market uptrend is under pressure.
You can follow Harrison Miller for more stock news and updates on Twitter @IBD_Harrison
YOU MAY ALSO LIKE:
See Stocks On The List Of Leaders Near A Buy Point
Short-Term Trades Can Add Up To Big Profits. IBD’s SwingTrader Shows You How
Watch IBD’s Investing Strategies Show For Actionable Market Insights
Learn How To Time The Market With IBD’s ETF Market Strategy
Market Rally Gets Reprieve; What To Look For In Friday’s Jobs Report
9/01/2022 Looking for the best stocks to buy and watch? Start by checking IBD Stock Of The Day for quick highlights…
9/01/2022 Looking for the best stocks to buy and watch? Start…
The Federal Reserve has been hoping to navigate a soft landing for the economy as it fights inflation pressures. That may be too optimistic. (© Gary Neill)
Get instant access to exclusive stock lists, expert market analysis and powerful tools with 2 months of IBD Digital for only $20!
Get market updates, educational videos, webinars, and stock analysis.
Learn how you can make more money with IBD’s investing tools, top-performing stock lists, and educational content.
Notice: Information contained herein is not and should not be construed as an offer, solicitation, or recommendation to buy or sell securities. The information has been obtained from sources we believe to be reliable; however no guarantee is made or implied with respect to its accuracy, timeliness, or completeness. Authors may own the stocks they discuss. The information and content are subject to change without notice.
*Real-time prices by Nasdaq Last Sale. Realtime quote and/or trade prices are not sourced from all markets.
Ownership data provided by Refinitiv and Estimates data provided by FactSet.
© 2000-2022 Investor’s Business Daily, LLC. All rights reserved